Compartir
Título
Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: A multicenter study
Autor(es)
Palabras clave
Antitachycardia pacing
Ventricular tachycardia
Implantable cardioverter-defibrillator
Fecha de publicación
2013-12
Editor
Wiley
Citación
Jiménez-Candil, J., Anguera, I., Ledesma, C., Fernández-Portales, J., Moríñigo, J. L., Dallaglio, P., Martín, A., Cano, T., Hernández, J., Sabaté, X., & Martín-Luengo, C. (2013). Morphology of far-field electrograms and antitachycardia pacing effectiveness among fast ventricular tachycardias occurring in ICD patients: A multicenter study. Journal of Cardiovascular Electrophysiology, 24(12), 1375-1382. https://doi.org/10.1111/JCE.12228
Resumen
[EN]Fast ventricular tachycardias (FVT) are less likely to be terminated by antitachycardia pacing (ATP). No information is available regarding the ability of far-field electrogram (Ff-EG) morphology (Ff-EGm) in predicting the result of the subsequent ATP. Our objective is to determine the relationship between Ff-EGm and ATP efficacy.
In this multicenter study we analyzed 289 FVT (cycle length [CL]: 250-320 milliseconds) occurring consecutively in 52 ICD patients with Medtronic devices (LVEF: 37 ± 6; pacing site: right ventricular apex). FVT programming was standardized, including a single ATP burst as initial therapy. The configuration of Ff-EG was HVA versus HVB. FVTs were classified in QFVT or non-QFVT according to the presence or absence of a negative initial deflection in the Ff-EG. The mean CL was 291 ± 24 milliseconds. We observed 4 Ff-EGm: QS (n = 14, 5%), QR (n = 158, 55%), R (n = 93, 32%), and RS (n = 24, 8%). The ATP effectiveness was 80% (86% in QS, 85% in QR, 74% in R, 62% in RS). The frequency of successful ATP was higher in QFVT: 86 versus 71% (P = 0.002). By logistic regression analysis, a QFVT pattern (OR = 2.3; P = 0.015) remained as an independent predictor of effective ATP. ATP was safer in QFVTs, the frequencies of shock (14% vs 29%; P = 0.002), acceleration (5.1 vs 12.3%; P = 0.02), and syncope (4.6 vs 12.3%; P = 0.01) being lower.
Since ATP is less effective in non-QFVTs, they are less well tolerated. Therefore, the substrate of non-QFVTs may need a specific treatment.
URI
ISSN
1045-3873
DOI
10.1111/jce.12228
Versión del editor
Aparece en las colecciones
Ficheros en el ítem
Nombre:
Tamaño:
1.563Mb
Formato:
Adobe PDF
Descripción:
Artículo principal, versión final













